BridgeBio Pharma, Inc 10-Q for FY2023 Q1
BridgeBio Pharma, Inc. (BBIO)
10-Q
2023-05-04
For: 2023-03-31
View Original
Added on
April 08, 2026
About this 10-Q
BridgeBio Pharma, Inc filed this 10-Q on May 4, 2023, covering the quarter ended March 31, 2023 (FY2023 Q1).
Headline figures
Quarter ended March 31, 2023, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $1.83M
- up 7.8% from $1.69M a year earlier
- Net loss
- $142.73M
- compared with a net loss of $201.33M a year earlier
- Diluted EPS
- -$0.92
- compared with -$1.35 a year earlier